> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Warning on ‘Copycat’ Bausch Eye Drops
- URL: https://www.fdaweb.com/warning-on-copycat-bausch-eye-drops/
- Published: 2024-01-31T12:00:00.000Z
- Updated: 2026-09-14T14:21:48.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156258

FDA has issued a warning on South Moon and Rebright or FivFivGo eye drops because of potential risks for eye infections. “These are copycat eye drop products that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for redness relief,” the [warning](https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-contaminated-copycat-eye-drops?utm%5Fmedium=email&utm%5Fsource=govdelivery) says.

FDA tested samples of South Moon and Rebright eye drops and *Burkholderia cepacia* complex, a group of bacteria that could result in an antibiotic-resistant infection, was detected. “While Rebright testing was negative for contamination, FDA recommends consumers not use this product,” the agency says.

FDA notes the copycat drops are unapproved drugs and should not be available for sale in the U.S. The warning includes photos comparing the similarity of copycats to the brand product.

“They claim to treat eye conditions such as glaucoma, which is treated with prescription drugs or surgery,” it says. “Patients who have signs or symptoms of an eye infection should talk to their health care provider or seek medical care immediately. FDA recommends consumers properly discard the products.”